March 30, 2017 3:36 AM ET

Pharmaceuticals

Company Overview of Novan, Inc.

Key Executives for Novan, Inc.

NameBoard RelationshipsTitleAge
Nathan Stasko Ph.D.6 RelationshipsCo-Founder, Chief Executive Officer, President and Director36
William L. Hodges CPA1 RelationshipsInterim Chief Financial Officer61
Stanley Hollenbach BS,J.D.No RelationshipsSenior Vice President of Research & Development--
Brian Johnson No RelationshipsChief Commercial Officer50
M. Joyce Rico M.D., MBANo RelationshipsChief Medical Officer62
View More Key Executives

Novan, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert A. Ingram 6 RelationshipsNovan, Inc.73
Nathan Stasko Ph.D. 6 RelationshipsNovan, Inc.36
Robert J. Keegan 20 RelationshipsTranstar Holding, Co.69
W. Kent Geer 14 RelationshipsNovan, Inc.61
Sean Edward Murphy 20 RelationshipsEvercore Partners Inc.63
View All Board Members

Novan, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee W. Kent Geer14 Relationships3 Executives
Compensation Committee Robert J. Keegan20 Relationships2 Executives
Nominating Committee Sean Edward Murphy20 Relationships3 Executives
Corporate Governance Committee Sean Edward Murphy20 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$340.0K
340.0K
345.2K
Bonus$174.0K
174.0K
502.7K
Total Short Term Compensation
Not meaningful
Total Value of Options$514.0K
514.0K
8.3M
Compensation as of Fiscal Year 2015
Novan, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Depomed, Inc. Announces Management Changes
March 28, 2017 9:03 PM ET
Mylan N.V. Appoints Daniel M. Gallagher as Chief Legal Officer on April 17, 2017
March 28, 2017 2:00 PM ET
ONL Therapeutics, Inc. Announces Management Changes
March 28, 2017 1:05 PM ET
Akcea Therapeutics Announces Board Appointments
March 28, 2017 12:00 PM ET
Laurus Labs Limited Announces Resignation of Frank J Wright as Director with Effect from March 31, 2017
March 27, 2017 2:54 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Novan, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.